{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:30:24Z","timestamp":1787956224632,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.neurobiolaging.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T10:09:42Z","timestamp":1454062182000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype"],"prefix":"10.1016","volume":"40","author":[{"given":"Jamaica R.","family":"Rettberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard N.","family":"Hodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor W.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"St. John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Diaz","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib1","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","article-title":"2014 Alzheimer's disease facts and figures","volume":"10","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1377\/hlthaff.2013.1353","article-title":"Alzheimer's disease in African Americans: risk factors and challenges for the future","volume":"33","author":"Barnes","year":"2014","journal-title":"Health Aff."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-005-0096-0","article-title":"The effect of conjugated equine oestrogen on diabetes incidence: the Women's health initiative randomised trial","volume":"49","author":"Bonds","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrendo.2015.82","article-title":"Perimenopause as a neurological transition state","volume":"11","author":"Brinton","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer's disease? Secondary \u201cprevention\u201d trials in Alzheimer's disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/geronb\/gbu086","article-title":"Deconstructing racial differences: the effects of quality of education and cerebrovascular risk factors","volume":"70","author":"Carvalho","year":"2015","journal-title":"J.\u00a0Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1089\/jwh.2011.2812","article-title":"Cognitive function and fine motor speed in older women with diabetes mellitus: results from the women's health initiative study of cognitive aging","volume":"20","author":"Espeland","year":"2011","journal-title":"J.\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/gps.4040","article-title":"Younger age of dementia diagnosis in a Hispanic population in southern California","volume":"29","author":"Fitten","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study","volume":"71","author":"Gottesman","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0079-6123(10)82003-5","article-title":"Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy","volume":"182","author":"Henderson","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib14","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.1073\/pnas.1312353110","article-title":"Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause","volume":"110","author":"Henderson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/GME.0000000000000343","article-title":"Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis","volume":"22","author":"Hodis","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.b.30114","article-title":"Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease","volume":"135B","author":"Holmans","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/jc.2014-1839","article-title":"Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women","volume":"100","author":"Karim","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2012.06.006","article-title":"Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease","volume":"34","author":"Kenna","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbadis.2013.10.016","article-title":"Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases","volume":"1842","author":"Kenney","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib23","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.2337\/dc12-2158","article-title":"Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans","volume":"36","author":"Mayeda","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer's disease: an analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-122074","article-title":"Biomarkers of Alzheimer's disease among Mexican Americans","volume":"34","author":"O'Bryant","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib26","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2337\/dc08-0577","article-title":"Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004","volume":"31","author":"Pani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: a cohort study","volume":"161","author":"Rawlings","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yfrne.2013.08.001","article-title":"Estrogen: a master regulator of bioenergetic systems in the brain and body","volume":"35","author":"Rettberg","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1212\/WNL.0000000000000269","article-title":"Association of type 2 diabetes with brain atrophy and cognitive impairment","volume":"82","author":"Roberts","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/WNL.49.6.1498","article-title":"Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study","volume":"49","author":"Seshadri","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrcardio.2014.15","article-title":"Impact of ethnicity on cardiac adaptation to exercise","volume":"11","author":"Sheikh","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"The Writing Group for the PEPI Trial, Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen\/progestin interventions (PEPI) trial","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-130245","article-title":"The KEEPS-cognitive and affective study: baseline associations between vascular risk factors and cognition","volume":"40","author":"Wharton","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mam.2011.10.005","article-title":"Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions","volume":"32","author":"Yao","year":"2011","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib36","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.neurobiolaging.2015.03.013","article-title":"The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity","volume":"36","author":"Yin","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.01.011_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000339957","article-title":"Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging","volume":"33","author":"Zeki Al Hazzouri","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T15:54:00Z","timestamp":1600098840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458016000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":37,"alternative-id":["S0197458016000129"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.01.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}